Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-080920

AGIOS PHARMACEUTICALS, INC. · AGIO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Period of report
Nov 16, 2015
Accepted (ET)
Nov 18, 2015 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001439222

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common stockF2Nov 16, 2015S1,213$59.38D141,789D
Common stockF2,F3Nov 16, 2015S1,213$59.38D141,789ISee footnote
Common stockF4Nov 17, 2015S3,490$59.99D138,299D
Common stockF5,F3Nov 17, 2015S3,492$59.98D138,297ISee footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses